MARAVAI LIFESCIENCES HOLDINGS, INC. - 8-K Filing

Maravai LifeSciences raises FY2026 revenue and Adjusted EBITDA guidance following 10% YoY Q3 revenue growth. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)

SEC EDGAR · November 4, 2026, 21:02 UTC

Tickers: $MRVI

Read the full article at SEC EDGAR

More Regulatory news

Stablecoin Development Corp - 8-K Filing SEC EDGAR · November 12, 2026, 13:40 UTC
BCP Investment Corp - 8-K Filing SEC EDGAR · November 12, 2026, 13:36 UTC
OneWater Marine Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:37 UTC
Moleculin Biotech, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:37 UTC
Investcorp Credit Management BDC, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:37 UTC
Presurance Holdings, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 13:35 UTC
Corteva, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:34 UTC
Ellington Financial Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:33 UTC
Neuronetics, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 13:33 UTC
ALLIANCE ENTERTAINMENT HOLDING CORP - 8-K Filing SEC EDGAR · November 12, 2026, 13:32 UTC